Gavin Arno1, Sarah Hull1, Keren Carss2, Arundhati Dev-Borman1, Christina Chakarova3, Kinga Bujakowska4, L Ingeborgh van den Born5, Anthony G Robson1, Graham E Holder1, Michel Michaelides1, Frans P M Cremers6, Eric Pierce4, F Lucy Raymond7, Anthony T Moore8, Andrew R Webster1. 1. UCL Institute of Ophthalmology, University College London, London, United Kingdom 2Moorfields Eye Hospital, London, United Kingdom. 2. Department of Haematology, University of Cambridge and NHS Blood and Transplant, Cambridge, United Kingdom 4NIHR BioResource - Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom. 3. UCL Institute of Ophthalmology, University College London, London, United Kingdom. 4. Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States. 5. Rotterdam Eye Hospital, Rotterdam, The Netherlands. 6. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands 8Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands. 7. NIHR BioResource - Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom 9Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom. 8. UCL Institute of Ophthalmology, University College London, London, United Kingdom 2Moorfields Eye Hospital, London, United Kingdom 10Ophthalmology Department, UCSF School of Medicine, Koret Vision Centre, San Francisco, California, United States.
Abstract
PURPOSE: Mutation of RGR, encoding retinal G-protein coupled receptor was originally reported in association with retinal dystrophy in 1999. A single convincing recessive variant segregated perfectly in one family of five affected and two unaffected siblings. At least one further individual, homozygous for the same variant has since been reported. The aim of this report was to reevaluate the findings in consideration of data from a whole genome sequencing (WGS) study of a large cohort of retinal dystrophy families. METHODS: Whole genome sequencing was performed on 599 unrelated probands with inherited retinal disease. Detailed phenotyping was performed, including clinical evaluation, electroretinography, fundus photography, fundus autofluorescence imaging (FAF) and spectral-domain optical coherence tomography (OCT). RESULTS: Overall we confirmed that affected individuals from six unrelated families were homozygous for both the reported RGR p.Ser66Arg variant and a nearby frameshifting deletion in CDHR1 (p.Ile841Serfs119*). All had generalized rod and cone dysfunction with severe macular involvement. An additional proband was heterozygous for the same CDHR1/RGR haplotype but also carried a second null CDHR1 mutation on a different haplotype. A comparison of the clinical presentation of the probands reported here with other CDHR1-related retinopathy patients shows the phenotypes to be similar in presentation, severity, and rod/cone involvement. CONCLUSIONS: These data suggest that the recessive retinal disorder previously reported to be due to homozygous mutation in RGR is, at least in part, due to variants in CDHR1 and that the true consequences of RGR knock-out on human retinal structure and function are yet to be determined.
PURPOSE: Mutation of RGR, encoding retinal G-protein coupled receptor was originally reported in association with retinal dystrophy in 1999. A single convincing recessive variant segregated perfectly in one family of five affected and two unaffected siblings. At least one further individual, homozygous for the same variant has since been reported. The aim of this report was to reevaluate the findings in consideration of data from a whole genome sequencing (WGS) study of a large cohort of retinal dystrophy families. METHODS: Whole genome sequencing was performed on 599 unrelated probands with inherited retinal disease. Detailed phenotyping was performed, including clinical evaluation, electroretinography, fundus photography, fundus autofluorescence imaging (FAF) and spectral-domain optical coherence tomography (OCT). RESULTS: Overall we confirmed that affected individuals from six unrelated families were homozygous for both the reported RGR p.Ser66Arg variant and a nearby frameshifting deletion in CDHR1 (p.Ile841Serfs119*). All had generalized rod and cone dysfunction with severe macular involvement. An additional proband was heterozygous for the same CDHR1/RGR haplotype but also carried a second null CDHR1 mutation on a different haplotype. A comparison of the clinical presentation of the probands reported here with other CDHR1-related retinopathy patients shows the phenotypes to be similar in presentation, severity, and rod/cone involvement. CONCLUSIONS: These data suggest that the recessive retinal disorder previously reported to be due to homozygous mutation in RGR is, at least in part, due to variants in CDHR1 and that the true consequences of RGR knock-out on human retinal structure and function are yet to be determined.
Authors: Jianye Zhang; Elliot H Choi; Aleksander Tworak; David Salom; Henri Leinonen; Christopher L Sander; Thanh V Hoang; James T Handa; Seth Blackshaw; Grazyna Palczewska; Philip D Kiser; Krzysztof Palczewski Journal: J Biol Chem Date: 2019-11-06 Impact factor: 5.157
Authors: Volha V Malechka; Catherine A Cukras; Emily Y Chew; Yuri V Sergeev; Delphine Blain; Brett G Jeffrey; Ehsan Ullah; Robert B Hufnagel; Brian P Brooks; Laryssa A Huryn; Wadih M Zein Journal: Genes (Basel) Date: 2022-05-22 Impact factor: 4.141
Authors: Gavin Arno; Keren J Carss; Sarah Hull; Ceniz Zihni; Anthony G Robson; Alessia Fiorentino; Alison J Hardcastle; Graham E Holder; Michael E Cheetham; Vincent Plagnol; Anthony T Moore; F Lucy Raymond; Karl Matter; Maria S Balda; Andrew R Webster Journal: Am J Hum Genet Date: 2017-01-26 Impact factor: 11.025
Authors: Keren J Carss; Gavin Arno; Marie Erwood; Jonathan Stephens; Alba Sanchis-Juan; Sarah Hull; Karyn Megy; Detelina Grozeva; Eleanor Dewhurst; Samantha Malka; Vincent Plagnol; Christopher Penkett; Kathleen Stirrups; Roberta Rizzo; Genevieve Wright; Dragana Josifova; Maria Bitner-Glindzicz; Richard H Scott; Emma Clement; Louise Allen; Ruth Armstrong; Angela F Brady; Jenny Carmichael; Manali Chitre; Robert H H Henderson; Jane Hurst; Robert E MacLaren; Elaine Murphy; Joan Paterson; Elisabeth Rosser; Dorothy A Thompson; Emma Wakeling; Willem H Ouwehand; Michel Michaelides; Anthony T Moore; Andrew R Webster; F Lucy Raymond Journal: Am J Hum Genet Date: 2016-12-29 Impact factor: 11.025
Authors: Xuan Bao; Zhaoxia Zhang; Yanjiang Guo; Christopher Buser; Harold Kochounian; Nancy Wu; Xiaohua Li; Shikun He; Bin Sun; Fred N Ross-Cisneros; Alfredo A Sadun; Lvzhen Huang; Mingwei Zhao; Henry K W Fong Journal: Am J Pathol Date: 2021-05-19 Impact factor: 5.770
Authors: Rola Ba-Abbad; Monique Leys; Xinjing Wang; Christina Chakarova; Naushin Waseem; Keren J Carss; F Lucy Raymond; Kinga M Bujakowska; Eric A Pierce; Omar A Mahroo; Moin D Mohamed; Graham E Holder; Marybeth Hummel; Gavin Arno; Andrew R Webster Journal: Invest Ophthalmol Vis Sci Date: 2018-10-01 Impact factor: 4.799